Natixis Advisors’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.52M | Sell |
12,248
-106,334
| -90% | -$30.6M | 0.01% | 906 |
|
|
2025
Q1 | $36.6M | Buy |
118,582
+104,847
| +763% | +$32.3M | 0.07% | 285 |
|
|
2024
Q4 | $4.85M | Sell |
13,735
-3,276
| -19% | -$1.16M | 0.01% | 831 |
|
|
2024
Q3 | $6.1M | Sell |
17,011
-739
| -4% | -$265K | 0.01% | 778 |
|
|
2024
Q2 | $5.65M | Buy |
17,750
+1,169
| +7% | +$372K | 0.01% | 757 |
|
|
2024
Q1 | $3.81M | Buy |
16,581
+531
| +3% | +$122K | 0.01% | 867 |
|
|
2023
Q4 | $3.53M | Sell |
16,050
-5,269
| -25% | -$1.16M | 0.01% | 854 |
|
|
2023
Q3 | $4.82M | Buy |
21,319
+7,702
| +57% | +$1.74M | 0.01% | 717 |
|
|
2023
Q2 | $3.01M | Buy |
13,617
+1,612
| +13% | +$356K | 0.01% | 858 |
|
|
2023
Q1 | $2.69M | Buy |
+12,005
| New | +$2.69M | 0.01% | 862 |
|
|
2014
Q2 | – | Sell |
-6,026
| Closed | -$567K | – | 1331 |
|
|
2014
Q1 | $567K | Buy |
6,026
+62
| +1% | +$5.83K | 0.01% | 917 |
|
|
2013
Q4 | $674K | Buy |
5,964
+126
| +2% | +$14.2K | 0.01% | 833 |
|
|
2013
Q3 | $460K | Buy |
5,838
+643
| +12% | +$50.7K | 0.01% | 862 |
|
|
2013
Q2 | $342K | Buy |
+5,195
| New | +$342K | 0.01% | 899 |
|